Literature DB >> 28451873

Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus.

Shuzo Sato1, Makiko Yashiro2, Tomoyuki Asano2, Hiroko Kobayashi2, Hiroshi Watanabe2, Kiyoshi Migita2.   

Abstract

Autoantibodies to triosephosphate isomerase (TPI), which is an important glycolytic enzyme in red blood cells and neuronal cells, have been reported to be associated with neuropsychiatric systemic lupus erythematosus (NPSLE) pathogenesis. However, the clinical features regarding anti-TPI antibody (anti-TPI)-positive NPSLE are not yet known. The aim of this study is to investigate the clinical features of anti-TPI-positive NPSLE patients using anti-TPI index values determined by enzyme-linked immunosorbent assay (ELISA). Thirty-one NPSLE patients treated in our department were included in this study. Serum samples were collected, and serum anti-TPI titers were measured by ELISA. The anti-TPI index values were defined as follows: (OD405 of samples - OD405 of negative control)/(OD405 of positive control - OD405 of negative control) × 100. Anti-TPI index values greater than 2 standard deviations above the mean of healthy controls were regarded as positive. The clinical features of anti-TPI-positive and anti-TPI-negative NPSLE were compared. Ten of the 31 NPSLE patients had anti-TPI positivity (32.3%). The clinical features of anti-TPI-positive NPSLE were comparable with those of anti-TPI-negative NPSLE, except for a higher frequency of aseptic meningitis (p = 0.027) and a lower frequency of acute confusional state (P = 0.026). Laboratory data in patients with anti-TPI-positive NPSLE showed significantly higher serum IgG levels. Furthermore, anti-TPI index values positively correlated with serum IgG levels. Our study indicates that serum anti-TPI increases in the presence of elevated IgG levels and can be associated with the pathogenesis of aseptic meningitis in NPSLE.

Entities:  

Keywords:  Aseptic meningitis; Systemic lupus erythematosus; Triosephosphate isomerase

Mesh:

Substances:

Year:  2017        PMID: 28451873     DOI: 10.1007/s10067-017-3653-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Authors:  F Orosz; G Wágner; K Liliom; J Kovács; K Baróti; M Horányi; T Farkas; S Hollán; J Ovádi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus.

Authors:  Tomomi Sasajima; Hiroshi Watanabe; Shuzo Sato; Yukio Sato; Hiromasa Ohira
Journal:  J Neuroimmunol       Date:  2006-10-24       Impact factor: 3.478

3.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus.

Authors:  L A DeGiorgio; K N Konstantinov; S C Lee; J A Hardin; B T Volpe; B Diamond
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

4.  Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus.

Authors:  Hiroshi Watanabe; Tomomi Seino; Yukio Sato
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

5.  Association between lupus psychosis and anti-ribosomal P protein antibodies.

Authors:  E Bonfa; S J Golombek; L D Kaufman; S Skelly; H Weissbach; N Brot; K B Elkon
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

6.  Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

Authors:  M T Herranz; G Rivier; M A Khamashta; K U Blaser; G R Hughes
Journal:  Arthritis Rheum       Date:  1994-04

Review 7.  The meninges: new therapeutic targets for multiple sclerosis.

Authors:  Abigail E Russi; Melissa A Brown
Journal:  Transl Res       Date:  2014-09-01       Impact factor: 7.012

Review 8.  Meningeal and cortical grey matter pathology in multiple sclerosis.

Authors:  Bogdan F Gh Popescu; Claudia F Lucchinetti
Journal:  BMC Neurol       Date:  2012-03-07       Impact factor: 2.474

9.  Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.

Authors:  Shunsei Hirohata; Yuko Sakuma; Tamiko Yanagida; Taku Yoshio
Journal:  Arthritis Res Ther       Date:  2014-10-02       Impact factor: 5.156

10.  Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.

Authors:  M Al-Obaidi; D Saunders; S Brown; L Ramsden; N Martin; E Moraitis; C A Pilkington; P A Brogan; D Eleftheriou
Journal:  Clin Rheumatol       Date:  2016-08-15       Impact factor: 2.980

View more
  3 in total

1.  Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.

Authors:  Jingjing Sun; Xue Li; Haotian Zhou; Xiaoyun Liu; Jingjing Jia; Qizhi Xie; Sijia Peng; Xiaolin Sun; Qingwen Wang; Li Yi
Journal:  J Immunol Res       Date:  2019-03-31       Impact factor: 4.818

Review 2.  Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.

Authors:  Shuzo Sato; Jumpei Temmoku; Yuya Fujita; Makiko Yashiro-Furuya; Naoki Matsuoka; Tomoyuki Asano; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2020-03-13

3.  Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus.

Authors:  Misato Jono; Yuhei Kinehara; Yoshihiko Utsu; Yoshiro Tamura; Masahiro Koseto; Teruaki Murakami; Akifumi Uota; Ryusuke Ninomiya; Satoshi Komo; Satoru Sumitani; Bunzo Sato; Soji Kasayama; Isao Tachibana
Journal:  Intern Med       Date:  2019-10-31       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.